There are benefits to postoperative administration of a low-molecular-weight-herapin subcutaneously the night after spine surgery, say Austrian researchers, according to an ORTHOSuperSite report.
The study was presented at the 2010 Annual Congress of the Spine Society of Europe in Vienna. The researchers examined 150 patients in a controlled cohort study and found that administering an antithrombotic agent the night after and up to four weeks after spinal surgery decreased the risk of fatal blood clots.
The difference in rate of complications was not statistically different.
Read the ORTHOSuperSit report on antithrombotic agents after spine surgery.
Read more about spine surgery studies:
- Study: Consider Disc Height Restoration in Patients With Foraminal Stenosis
- Study: MRI for Spine Surgery May Lead to Unnecessary Surgery
- Cortoss Could Be Safe for Vertebroplasty or Kyphoplasty Patients
The study was presented at the 2010 Annual Congress of the Spine Society of Europe in Vienna. The researchers examined 150 patients in a controlled cohort study and found that administering an antithrombotic agent the night after and up to four weeks after spinal surgery decreased the risk of fatal blood clots.
The difference in rate of complications was not statistically different.
Read the ORTHOSuperSit report on antithrombotic agents after spine surgery.
Read more about spine surgery studies:
- Study: Consider Disc Height Restoration in Patients With Foraminal Stenosis
- Study: MRI for Spine Surgery May Lead to Unnecessary Surgery
- Cortoss Could Be Safe for Vertebroplasty or Kyphoplasty Patients